Technology Licensing opportunities

Available technologies

Clear search
In-situ measurement for 2d-material exfoliation

An online monitoring system that can monitor layered 2D material production in a liquid dispersion, in real time

Graphene Fluidic exfoliation

A novel approach to liquid exfoliation to achieve more efficient and cost-effective production of 2D materials at any scale

Data-driven Multiplexing for Accurate Gene Detection

Machine learning approach for high-level multiplexing in qPCR and dPCR, up to 21-plex demonstrated

Artificial Golgi Reactor for Tailoring Glycans

A novel platform comprising immobilized enzymes to produce homogenously glycosylated proteins for therapeutic or diagnostic applications.

Novel living ring-opening polymerisation method to synthesise a novel class of multifunctional, sequence-controlled, degradable and biocompatible polymers

A simple, scalable and cost-effective polymerisation method for synthesis of a class of novel, multifunctional, sequence-controlled, degradable and biocompatible polymers.

Ionic liquids with excipients as stabilisers for payloads in solution

Ionic liquid formulations that stabilise a range of payloads, antibodies and RNA-based systems, allowing pharmaceuticals to be storied in solution at room temperature.

Bioharmonophores for biomedical precision imaging

Biodegradable, second-harmonic generating nanoprobes for targeted, high-resolution in vivo tumour imaging

SIMPLE: Single Incision Micro Ports for Laparoscopic Endo-surgery

A next generation surgical robotics platform for ultra-minimally invasive surgery via a single port, offering bimanual haptic control and enabling autonomous surgical tasks.

Circuit design for limiting Mycoplasma growth to bioreactors

Inducible systems developed for use in Mycoplasma species. These tools will contribute to the exploitation of Mycoplasma as a synthetic biology asset.

Dual DNA-PK/AKT inhibition for the treatment of platinum-resistant cancer

Novel compounds with dual DNA-PK/AKT inhibitor activity for the treatment of platinum-resistant cancers.



Subscribe for Licensing Opportunities updates
Keep up to date with new technologies and licensing opportunities coming out of Imperial College London